161 related articles for article (PubMed ID: 1253632)
1. Fosfomycin in Osteomyelitis.
Fernandez-Valencia JE; Saban T; Cañedo T; Olay T
Chemotherapy; 1976; 22(2):121-34. PubMed ID: 1253632
[TBL] [Abstract][Full Text] [Related]
2. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
Wolff M; Nercelles P; Pepay K
Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621
[No Abstract] [Full Text] [Related]
3. Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus.
Poeppl W; Tobudic S; Lingscheid T; Plasenzotti R; Kozakowski N; Georgopoulos A; Burgmann H
Antimicrob Agents Chemother; 2011 Feb; 55(2):931-3. PubMed ID: 21098253
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience with fosfomycin-sodium in purulent osteomyelitis (author's transl)].
Yoh K; Hatanaka I; Nakano K
Jpn J Antibiot; 1981 Oct; 34(10):1387-94. PubMed ID: 7334575
[No Abstract] [Full Text] [Related]
5. Vertebral osteomyelitis caused by vancomycin-tolerant methicillin-resistant Staphylococcus aureus bacteremia: Experience with teicoplanin plus fosfomycin combination therapy.
Lee WS; Chen YC; Chen HP; Chen TH; Cheng CY
J Microbiol Immunol Infect; 2016 Aug; 49(4):600-3. PubMed ID: 24269007
[TBL] [Abstract][Full Text] [Related]
6. Fosfomycin for the initial treatment of acute haematogenous osteomyelitis.
Corti N; Sennhauser FH; Stauffer UG; Nadal D
Arch Dis Child; 2003 Jun; 88(6):512-6. PubMed ID: 12765918
[TBL] [Abstract][Full Text] [Related]
7. Imipenem plus Fosfomycin as Salvage Therapy for Vertebral Osteomyelitis.
Nakamura I; Yamaguchi T; Aoki K; Miura Y; Sato S; Fujita H; Watanabe H
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 32958715
[TBL] [Abstract][Full Text] [Related]
8. Fosfomycin in a traumatological department.
Hernández Casado V
Chemotherapy; 1977; 23 Suppl 1():403-10. PubMed ID: 832541
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
[TBL] [Abstract][Full Text] [Related]
10. [Staphylococcus aureus meningitis with intermediate sensitivity to glycopeptides. Therapeutic indications].
Pofelski J; Pavese P; Brion JP; Marrakchi C; Gay E; Recule C; Stahl JP
Presse Med; 2003 Feb; 32(5):217-20. PubMed ID: 12610462
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of ventriculitis caused by Staphylococcus epidermidis on equipment with the combination of fosfomycin and an aminoglycoside. Course of ventricular levels of fosfomycin].
Boulard G; Quentin C; Scontrini G; Dautheribes M; Pouguet P; Sabathie M
Pathol Biol (Paris); 1983 Jun; 31(6):525-7. PubMed ID: 6348662
[TBL] [Abstract][Full Text] [Related]
12. [Resistance of staphylococci to intracellular killing by macrophages--a new pathophysiologic concept of acute hematogenous osteomyelitis in childhood and its therapeutic consequences].
Guggenbichler JP; Bonatti H; Rottensteiner F
Padiatr Padol; 1989; 24(1):21-32. PubMed ID: 2717189
[TBL] [Abstract][Full Text] [Related]
13. [Importance of the cefotaxime-fosfomycin combination. Apropos of a case of meningitis due to heterogeneously resistant Staphylococcus aureus].
Tremeaux JC; Duez JM; Pechinot A; Sautreaux JL; Thierry A; Kazmierczak A
Agressologie; 1983 Apr; 24(4):169-71. PubMed ID: 6314832
[No Abstract] [Full Text] [Related]
14. Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats.
Lingscheid T; Poeppl W; Bernitzky D; Veletzky L; Kussmann M; Plasenzotti R; Burgmann H
Antimicrob Agents Chemother; 2015 Feb; 59(2):859-63. PubMed ID: 25403675
[TBL] [Abstract][Full Text] [Related]
15. Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections.
Pääkkönen M; Kallio PE; Kallio MJ; Peltola H
Pediatr Infect Dis J; 2012 May; 31(5):436-8. PubMed ID: 22189524
[TBL] [Abstract][Full Text] [Related]
16. [Fosfomycin-cefotaxime combination in severe staphylococcal infections in newborn infants].
Gouyon JB; Duez JM; Portier H; Brichon P; Kohli E; Alison M
Presse Med; 1985 Dec; 14(42):2135-8. PubMed ID: 2935798
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak A; Mundy LM
Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
[No Abstract] [Full Text] [Related]
18. [Clinical trial of fosfomycin for Campylobacter enteritis].
Nogawa T; Takeuchi Y; Watanabe J; Kimura K; Tomii I; Abe T; Watanabe Y; Nakasone K; Fujimori I; Kobayashi Y
Jpn J Antibiot; 1984 Sep; 37(9):1620-4. PubMed ID: 6512981
[TBL] [Abstract][Full Text] [Related]
19. Fosfomycin in chronic urinary infections.
Allona A; Díaz Cabrera JA; Manchado P
Chemotherapy; 1977; 23 Suppl 1():267-74. PubMed ID: 851501
[TBL] [Abstract][Full Text] [Related]
20. [The behavior of Staphylococcus aureus responsible for hospital infections in the presence of phosphomycin activity in vitro].
Mendonca CP; Lourenço VL; Shimizu MT; Natalino PR; Anno IS
Rev Saude Publica; 1975 Mar; 9(1):11-4. PubMed ID: 1145089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
